Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    21397720 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
Condition: HIV Infections
Interventions: Biological: Hepatitis B virus vaccine with GM-CSF adjuvant;   Biological: Hepatitis B virus vaccine
To Top

† Indicates status has not been verified in more than two years